Cited by 74Gestational Diabetes Research and ManagementNatural Antidiabetic Agents StudiesPregnancy and Medication Impact

Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials

Vitagliano, Amerigo, Saccone, Gabriele, Cosmi, Erich, Visentin, Silvia, Dessole, Francesco, Ambrosini, Guido, Berghella, Vincenzo·2019·Archives of Gynecology and Obstetrics

Abstract

Purpose Inositol (ISL) embraces a family of simple carbohydrates with insulin-sensitizing properties, whose most common isoforms are Myo-inositol (MYO) and D-chiro inositol (DCI). The aim of the present study was to assess the efficacy and safety of ISL supplementation during pregnancy for the prevention of gestational diabetes (GDM).Methods We conducted a systematic literature search in electronic databases until October 2017. We included all randomized controlled trials (RCTs) comparing pregnant women with GDM who were randomized to either ISL (i.e., intervention group) or either placebo or no treatment (i.e., control group). The primary outcome was the preventive effect on GDM, defined as the rate of GDM in women without a prior diagnosis of GDM. Pooled results were expressed as odds ratio (OR) with a 95% confidence interval (95% CI).Results Five RCTs were included (including 965 participants). ISL supplementation was associated with lower rate of GDM (OR 0.49, 95% CI 0.24-1.03, p = 0.01) and lower preterm delivery rate (OR 0.35, 95% CI 0.17-0.74, p = 0.006). No adverse effects were reported. Adjusting for the type of intervention (MYO 2 g twice daily vs MYO 1100 mg plus DCI 27.6 mg daily), a significant effect was found only in patients receiving 2 g MYO twice daily.Conclusions ISLs administration during pregnancy appears to be safe and may represent a novel strategy for GDM prevention. In particular, the double administration of MYO 2 g per day may improve the glycemic homeostasis and may reduce GDM rate and preterm delivery rate.

Integrity signals

Registry

Crossref · 10.1007/s00404-018-5005-0

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vitagliano, A., Saccone, G., Cosmi, E., Visentin, S., Dessole, F., Ambrosini, G., & Berghella, V.
Affiliations
  • University of Padua (IT)
  • University of Naples Federico II (IT)
  • University of Sassari (IT)
  • Thomas Jefferson University (US)
Corresponding author
Vitagliano, Amerigo
Venue
Archives of Gynecology and Obstetrics
Published
2018-12-18
Volume
299
Issue
1
Pages
55-68
ISSN
  • 0003-9128 (ISSN-L)
  • 0932-0067
  • 1432-0711
OpenAlex
W2905576351
Cited by
74
References
41
Citations by year
2026: 4 · 2025: 6 · 2024: 6 · 2023: 13 · 2022: 11 · 2021: 13 · 2020: 15 · 2019: 6
FWCI
1.38
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Gynecology and Obstetrics (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
inositol supplementation, gestational diabetes prevention, myo-inositol, D-chiro-inositol, pregnancy, preterm birth, insulin sensitivity, glycemic homeostasis, supplement dosage
MeSH terms
Adult, Blood Glucose, Female, Humans, Infant, Newborn, Inositol, Insulin, Pregnancy, Vitamin B Complex, Odds Ratio, Randomized Controlled Trials as Topic, Diabetes, Gestational, Premature Birth, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review